Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines has raised $300.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Beeline Medicines's investors include Bain Capital.
Beeline Medicines is headquartered in Boston, United States.
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beeline Medicines — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/beeline-medicines. Accessed November 15, 2026.
VCBacked. (2026). Beeline Medicines — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/beeline-medicines
{{cite web |title=Beeline Medicines — Funding & Investors |url=https://www.vcbacked.co/company/beeline-medicines |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Beeline Medicines? Request a listing update